Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127415011 | 12741501 | 1 | I | 20160831 | 0 | 20160913 | 20160913 | DIR | FDA-CTU | 6.17 | YR | M | N | 23.50000 | KG | 20160912 | N | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127415011 | 12741501 | 1 | PS | METHOTREXATE. | METHOTREXATE | 1 | 0 | 890 | MG | ||||||||||
| 127415011 | 12741501 | 2 | SS | ONCASPAR | PEGASPARGASE | 1 | 0 | 2225 | IU | ||||||||||
| 127415011 | 12741501 | 3 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | 0 | 1.3 | MG | ||||||||||
| 127415011 | 12741501 | 4 | C | MELATONIN | MELATONIN | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127415011 | 12741501 | Diarrhoea | |
| 127415011 | 12741501 | Pyrexia | |
| 127415011 | 12741501 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127415011 | 12741501 | 1 | 20160826 | 0 | ||
| 127415011 | 12741501 | 2 | 20160826 | 0 | ||
| 127415011 | 12741501 | 3 | 20160817 | 0 |